IL-10 and IL-4 synergize with TNF-α to induce IL-1ra production by human neutrophils

Cytokine

Volumn 8, Issue 2, 1996, Pages 147-151

  Marie, Christelle ^a   Pitton, Christina ^a   Fitting, Catherine ^a   Cavaillon, Jean Marc ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

IL 1 receptor antagonist; Inflammation; Lipopolysaccharide; Neutrophils; TNF

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0029875029     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0021     Document Type: Article

References (29)

1. Bogdan C, Paik J, Vodovotz Y, Nathan C (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 267:23301-23308.
2. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE (1993) Effect of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 151:6370-6381.
3. Pradier O, Gérard C, Delvaux A, Lybin M, Abramowicz D, Capel P, Velu T, Goldman (1993) Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700-2703.
4. Herbert JM, Savi P, Laplace MC, Lalé A, Dol F, Duams A, Labit C, Minty A (1993) IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS 328:268-270.
5. Mulligan MS, Jones ML, Vapociyan AA, Howard MC, Ward PA (1993) Protective effects of IL-4 and IL-13 against immune complex-induced lung injury. J Immunol 151:5666-5674.
6. Shull MM, Ormsby I, Kier A, Pawloski, S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Nannunziata N, Doetschman T (1992) Targeted distuption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-699.
7. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M (1991) Induction of the interleukin-1 receptor antagonist protein by transforming growth factor-β. Eur J Immunol 21:1635-1639.
8. Orino E, Sone S, Nii A, Ogura T (1992) IL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J Immunol 149:925-931.
9. Jenkins JK, Malyak M, Arend WP (1994) The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphok Cyt Res 13:47-54.
10. Yanagawa H, Sone S, Haku T, Mizuno K, Yano S, Ohmoto Y, Ogura T (1995) Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 12:71-76.
11. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652.
12. Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550-552.
13. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA (1991) A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 5:338-343.
14. Aiura K, Gelfand JA, Burke JF, Thompson RC, Dinarello CA (1993) Interleukin-1 receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1β in rabbits. Infect Immun 61:3342-3350.
15. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA (1991) Production of interleukin-1 receptor antagonist during experimental endotoxaemia. Lancet 338:1423-1424.
16. Rogy MA, Coyle SM, Oldenburg HSA, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF (1994) Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 1978:132-138.
17. Fisher E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarell CA, Lowry SF, Moldawer LL (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196-2200.
18. Jakobsen PH, McKay V, Morris-Jones SD, McGuire W, van Hensbroek MB, Meisner S, Bendtzen K, Schousboe I, Bygbjerg IC, Greenwood MB (1994) Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein-I in Gambian children with cerebral malaria. Infect Immun 62:4374-4379.
19. Mandrup-Poulsen T, Wogensen L, Jensen M, Svensson P, Nilsson P, Emdal T, Molvig J, Dinarello CA, Nerup J (1995) Circulating interleukin-1 receptor antagonist concentrations are increased in adults patients with thermal injury. Crit Care Med 23:26-33.
20. Hammerberg C, Arend WP, Fisher GJ, Chan LS, Berger AE, Haskill JS, Voorhees JJ, Cooper KD (1992) Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 90:571-583.
21. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P (1995) Balance between IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. Immunol 154:1432-1439.
22. Casini-Raggi V, Kam L, Chong YJT, Fiochhi C, Pizarro TT, Cominelli F (1995) Mucosal imbalance of IL-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154:2434-2440.
23. McColl SR, Paquin R, Ménard C, Beaulieu AD (1992) Human neutrophils produce high levels of the interleukin-1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-α. J Exp Med 176:593-598.
24. Re F, Mengozzi M, Muzio M, Dinarello CA, Mantovani A, Colotta F (1993) Expression of interleukin-1 receptor antagonist human circulating polymorphonuclear cells. Eur J Immunol 23:570-573.
25. Malyak M, Smith MF, Abel AA, Arend WP (1994) Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β. J Clin Immunol 14:20-30.
26. Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D, Minty A, Ferrara P, Mantovani A, Colotta F (1994) Interleukin-13 induces the production of interleukin-1 receptor antagonist and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 83:1738-1743.
27. Muzio M, Sironi M, Polentarutti A, Colotta F (1994) Induction by transforming growth factor-β1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur J Immunol 24:3194-3198.
28. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S (1994) Interleukin-10 upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179:1695-1699.
29. van der Poll T, van Deventer SJH, ten Cate J, Levi M, ten Cate JW (1994) Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxaemia. J Infect Dis 169:665-667.